BiotechTube
Home/Prothena/Gene G. Kinney, Ph.D.
GG

Gene G. Kinney, Ph.D.

President and Chief Executive Officer, Director

Prothena

Therapeutic Areas

Neurodegenerative DiseasesRare DiseasesAmyloidosis

Prothena Pipeline

DrugIndicationPhase
PrasinezumabParkinson’s DiseasePhase 2b
Coramitug (PRX004)ATTR AmyloidosisPhase 1
BMS-986446 (PRX005)Alzheimer’s DiseasePhase 1
PRX019Alzheimer’s DiseaseNot Specified (Preclinical/Discovery)